RECOMBINANT POLYPEPTIDE FOR DISRUPTING INTERACTION OF EAG2 AND KVß2 AND THERAPEUTIC… Application WO-2023065046-A1 World Intellectual Property Organisation (WIPO) 27 Apr 2023